Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer. Breast Cancer Res Treat. 2016 06; 157(3):475-88.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
Benzamides
Benzamides
Cell Line, Tumor
Cell Line, Tumor
Cell Nucleus
Cell Nucleus
Cell Proliferation
Cell Proliferation
Cell Survival
Cell Survival
Drug Synergism
Drug Synergism
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Mice
Mice
Nitriles
Nitriles
Phenylthiohydantoin
Phenylthiohydantoin
Phosphatidylinositol 3-Kinases
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-akt
Receptors, Androgen
Receptors, Androgen
Rotenone
Rotenone
Signal Transduction
Signal Transduction
Sirolimus
Sirolimus
TOR Serine-Threonine Kinases
TOR Serine-Threonine Kinases
Triple Negative Breast Neoplasms
Triple Negative Breast Neoplasms
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Robert H Cichewicz